News

The in-vivo maximisation sensitisation test method is designed to evaluate the allergenic potential or sensitising capacity of DispersinB wound spray. According to the company, the biocompatibility results confirm

Kendle has posted a net income of $1.55m for the third quarter 2010, or $0.1 per diluted share, compared to net income of $8.83m, or $0.59 per diluted

BDI’s portfolio includes branded and generic specialty pharmaceuticals, chemotherapy products, vaccines, albumin, IVIG, coagulation factors, high-titer or hyper immune globulins and other specialty injectables. BDI IT VP Tim

The patented, gene expression test uses a simple, noninvasive method of blood sample collection and can show the low probability of acute cellular rejection in stable heart transplant

The addition of MedAppz’ iSuite EHR broadens MedLink’s technology offerings, enabling the company to provide a web-based solution built on the latest Microsoft .Net 4.0 platform. MedAppz claims

Mitsui has invested $12.5m in cash in return for new convertible Preference Shares giving Mitsui 12.2% of the enlarged share capital of Hutchison MediPharma. Mitsui Global Investment Department

GLG Pharma said that the proceeds of the grant will be used to advance the development of three product candidates, GLG-202, GLG-302, GLG-401, all STAT3 inhibitors, representing a

Accoding to Affymax, the decrease in revenue was the result of decreased collaboration revenue, driven primarily by lower reimbursement of clinical trial expenses, from its collaboration with Takeda

EnVivo claimed that, by acting as a co-agonist and sensitising the alpha-7 receptor, EVP-6124 makes it possible for smaller amounts of naturally occurring ACh, typically found in individuals